Literature DB >> 29491100

A Retrospective Multicenter Study of Carbon Ion Radiotherapy for Locally Advanced Olfactory Neuroblastomas.

Hiroaki Suefuji1, Masashi Koto2, Yusuke Demizu3, Jun-Ichi Saitoh4, Yoshiyuki Shioyama5, Hiroshi Tsuji2, Tomoaki Okimoto3, Tatsuya Ohno4, Kenji Nemoto6, Takashi Nakano4, Tadashi Kamada2.   

Abstract

The purpose was to evaluate efficacy and safety of carbon ion radiotherapy (C-ion RT) in patients with locally advanced olfactory neuroblastomas (ONBs). This study was a sub-analysis of the Japan Carbon-Ion Radiation Oncology Study Group Study (1402 HN, UMIN000024473). Clinical data of T4 ONBs treated with C-ion RT at four Institutions between November 2003 and December 2014 were retrospectively reviewed. Twenty-one patients underwent C-ion RT. Seven patients had T4a and 14 had T4b tumours without cervical node metastases. The median follow-up period was 39 (range=5-111) months. The 3-year overall survival and local control rates were 88.4% and 83.0%, respectively. Grade 4 late toxicity was observed in three patients, including ipsilateral optic nerve disorder (n=2) and ipsilateral retinopathy (n=1). C-Ion RT is effective and can be a curative modality for T4 ONBs. Prospective multicenter studies are warranted to confirm these findings. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Olfactory neuroblastoma; cancer of the head and neck; carbon ion radiotherapy; multicenter study; radiotherapy

Mesh:

Year:  2018        PMID: 29491100     DOI: 10.21873/anticanres.12399

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Advanced Radiation Techniques in the Treatment of Esthesioneuroblastoma: A 7-Year Single-Institution's Clinical Experience.

Authors:  Jakob Liermann; Mustafa Syed; Thomas Held; Denise Bernhardt; Peter Plinkert; Christine Jungk; Andreas Unterberg; Stefan Rieken; Jürgen Debus; Klaus Herfarth; Sebastian Adeberg
Journal:  Cancers (Basel)       Date:  2018-11-20       Impact factor: 6.639

2.  A retrospective multicenter study of carbon-ion radiotherapy for external auditory canal and middle ear carcinomas.

Authors:  Kazuhiko Hayashi; Masashi Koto; Yusuke Demizu; Jun-Ichi Saitoh; Hiroaki Suefuji; Tomoaki Okimoto; Tatsuya Ohno; Yoshiyuki Shioyama; Ryo Takagi; Hiroaki Ikawa; Kenji Nemoto; Takashi Nakano; Tadashi Kamada
Journal:  Cancer Med       Date:  2018-12-08       Impact factor: 4.452

3.  Management of orbital invasion in esthesioneuroblastoma: 14 years' experience.

Authors:  Ruichen Li; Shu Tian; Yi Zhu; Li Yan; Wenjia Zhu; Huatao Quan; Shengzi Wang
Journal:  Radiat Oncol       Date:  2019-06-13       Impact factor: 3.481

4.  Multicenter study of carbon-ion radiation therapy for nonsquamous cell carcinomas of the oral cavity.

Authors:  Hiroaki Ikawa; Masashi Koto; Yusuke Demizu; Jun-Ichi Saitoh; Hiroaki Suefuji; Tomoaki Okimoto; Tatsuya Ohno; Yoshiyuki Shioyama; Ryo Takagi; Kazuhiko Hayashi; Kenji Nemoto; Takashi Nakano; Tadashi Kamada
Journal:  Cancer Med       Date:  2019-08-01       Impact factor: 4.452

5.  Intensity-modulated particle beam radiation therapy in the management of olfactory neuroblastoma.

Authors:  Weixu Hu; Jiyi Hu; Jing Gao; Jing Yang; Xianxin Qiu; Lin Kong; Jiade J Lu
Journal:  Ann Transl Med       Date:  2020-08

Review 6.  Who Will Benefit from Charged-Particle Therapy?

Authors:  Kyung Su Kim; Hong-Gyun Wu
Journal:  Cancer Res Treat       Date:  2021-06-21       Impact factor: 4.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.